Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01059929 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)
A Phase 4 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT01059929: Clinical Trial Phase 4 study, sponsored by University of Chicago.
NCT01059929 is a Phase 4 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 41 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01059929, a Phase 4 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to compare propofol to dexmedetomidine for prolonged sedation (\> 24 hours) in critically ill patients who require mechanical ventilation.
Primary Outcome
delirium assessment using CAM-ICU
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Propofol
- DRUG Fentanyl
- BEHAVIORAL Physical and Occupational Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Why NCT01059929 stopped before completion
NCT01059929 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which Midazolam is the first listed.
NCT01059929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01059929 about?
NCT01059929 is a clinical study titled "Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)". This is a randomized controlled trial to compare propofol to dexmedetomidine for prolonged sedation (\> 24 hours) in critically ill patients who require mechanical ventilation.
What is the current status of trial NCT01059929?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2009-09. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01059929?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG), Fentanyl (DRUG), Physical and Occupational Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01059929?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01059929's enrollment target sits among peer trials
41 1390th of 2000 higher than 604 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia